Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


The uncertainty principle and industry-sponsored research.

Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH.

Lancet. 2000 Aug 19;356(9230):635-8.


Sponsors' participation in conduct and reporting of industry trials: a descriptive study.

Lundh A, Krogsbøll LT, Gøtzsche PC.

Trials. 2012 Aug 24;13:146. doi: 10.1186/1745-6215-13-146.


Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Als-Nielsen B, Chen W, Gluud C, Kjaergard LL.

JAMA. 2003 Aug 20;290(7):921-8.


Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.

Clifford TJ, Barrowman NJ, Moher D.

BMC Health Serv Res. 2002 Sep 4;2(1):18.


An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Montgomery JH, Byerly M, Carmody T, Li B, Miller DR, Varghese F, Holland R.

Control Clin Trials. 2004 Dec;25(6):598-612. Review.


Bias from industry trial funding? A framework, a suggested approach, and a negative result.

Barden J, Derry S, McQuay HJ, Moore RA.

Pain. 2006 Apr;121(3):207-18. Epub 2006 Feb 21.


Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.

Conen D, Torres J, Ridker PM.

Circulation. 2008 Sep 23;118(13):1321-7. doi: 10.1161/CIRCULATIONAHA.108.794016. Epub 2008 Sep 8.


Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development.

Fries JF, Krishnan E.

Arthritis Res Ther. 2004;6(3):R250-5. Epub 2004 Mar 18.


Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions.

Jørgensen AW, Maric KL, Tendal B, Faurschou A, Gøtzsche PC.

BMC Med Res Methodol. 2008 Sep 9;8:60. doi: 10.1186/1471-2288-8-60.


Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.

Flacco ME, Manzoli L, Boccia S, Capasso L, Aleksovska K, Rosso A, Scaioli G, De Vito C, Siliquini R, Villari P, Ioannidis JP.

J Clin Epidemiol. 2015 Jul;68(7):811-20. doi: 10.1016/j.jclinepi.2014.12.016. Epub 2015 Feb 7. Review.


Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology.

Knox KS, Adams JR, Djulbegovic B, Stinson TJ, Tomor C, Bennet CL.

Ann Oncol. 2000 Dec;11(12):1591-5.


Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Khan NA, Lombeida JI, Singh M, Spencer HJ, Torralba KD.

Arthritis Rheum. 2012 Jul;64(7):2059-67. doi: 10.1002/art.34393.


Evaluating non-randomised intervention studies.

Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group.

Health Technol Assess. 2003;7(27):iii-x, 1-173. Review.


Industry funding and the reporting quality of large long-term weight loss trials.

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB.

Int J Obes (Lond). 2008 Oct;32(10):1531-6. doi: 10.1038/ijo.2008.137. Epub 2008 Aug 19. Review.


Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

Ridker PM, Torres J.

JAMA. 2006 May 17;295(19):2270-4. Erratum in: JAMA. 2006 Jun 21;295(23):2726.


Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Lexchin J, Bero LA, Djulbegovic B, Clark O.

BMJ. 2003 May 31;326(7400):1167-70. Review.


Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

Golder S, Loke YK.

Br J Clin Pharmacol. 2008 Dec;66(6):767-73. doi: 10.1111/j.1365-2125.2008.03272.x. Epub 2008 Jul 31. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk